The prediction and classification of skin irritation potential of substances can be performed by the assessment of the effect on EpiDerm™ and SkinEthic™ RHE (Reconstructed Human Epidermis) models.
The human skin model test is validated by the EURL ECVAM (European Union Reference Laboratory for Alternatives to Animal Testing) and is performed in accordance with the OECD guidance OECD 439 at Eurofins BioPharma Product Testing Munich GmbH1 with chemicals, cosmetics or personal care products and pharmaceuticals.
Principles of the Human Skin Model Test
Protocol |
||
Model |
EpiDerm™ |
SkinEthic™ RHE |
Supplier |
MatTek |
SkinEthic |
Analysis |
Skin irritation potential: cytotoxicity measurement with MTT (mean tissue viability compared to negative control) |
|
Test chemical concentrations |
Liquids: 30 µL (undiluted) Solids: 25 mg + 25 µL DPBS |
Liquids: 16 µL (undiluted) Solids: 16 mg + 10 µL Aqua dest. |
Exposure time and incubation periods |
60 min incubation with dose groups 24 h post-incubation and further 18 h incubation in media |
42 min incubation with dose groups 42 h post-incubation |
Quality controls |
Positive control: 5% SDS Negative control: DPBS |
|
Pre-tests |
To determine if additional controls are needed: NSMTT*: mixing of test item with MTT medium to determine if test item alone can reduce MTT à blue colouring: in main experiment two (EpiDerm™) or three (SkinEthic™ RHE) killed tissues treated with test item and two or three untreated killed tissues are added as controls NSCliving#: mixing of test item with H2O or isopropanol to determine if strong colour of test item can discolour at contact with this liquids à optical discolouring (measuring of spectrum): in main experiment two (EpiDerm™) or three (SkinEthic™ RHE) living tissues without incubation with MTT medium are added as controls NSCkilled§: if the two other controls were determined à in main experiment two (EpiDerm™) or three (SkinEthic™ RHE) killed tissues without incubation with MTT medium are added as controls |
|
Application |
Direct topical application of chemicals on skin tissues Three tissue replicates per dose group |
|
Data delivery |
Optical density (OD) value with microplate spectrophotometer at 570 nm |
|
Prediction model |
Mean tissue viability (% negative control): ≤ 50%: Irritant (I): UN GHS at least "Category 2" (IL-1α > 60 pg/mL) > 50%: Non-Irritant (NI): UN GHS "No Category" (IL-1α ≤ 60 pg/mL) |
*NSMTT: non-specific MTT reduction
#NSCliving: non-specific colouring of living tissues
$NSCkilled: non-specific colouring of killed tissues
Eurofins Data for demonstration technical proficiency of the Human Skin Model Test (EpiDerm™ and SkinEthic™ RHE)
Chemical |
UN GHS category |
EF category for EpiDerm™ |
EF category for SkinEthic™ RHE |
Non-Classified Chemicals (UN GHS "No Category") |
|||
Naphthalene acetic acid |
No Category |
No Category |
No Category |
Isopropanol |
No Category |
No Category |
No Category |
Methyl stearate |
No Category |
No Category |
No Category |
Heptyl butyrate |
No Category |
No Category |
No Category |
Hexyl salicylate |
No Category |
No Category |
No Category |
Classified Chemicals (UN GHS "Category 2") |
|||
Cyclamen aldehyde |
Category 2 |
Category 2 |
Category 2 |
1-Bromohexane |
Category 2 |
Category 2 |
Category 2 |
Potassium hydroxide (5% KOH) |
Category 2 |
Category 2 |
Category 2 |
1-Methyl-3-phenyl-1-piperazine |
Category 2 |
Category 2 |
Category 2 |
Heptanal |
Category 2 |
Category 2 |
Category 2 |
EF = Eurofins Munich GmbH
Table 1: Eurofins data of in vitro skin irritation with EpiDerm™ and SkinEthic™ RHE of ten tested proficiency chemicals compared to the data of the OECD guideline 4391.
In Table 1 the obtained data from the in vitro skin irritation with EpiDerm™ and SkinEthic™ RHE of five non-classified and five classified ("Category 2") chemicals are shown. The prediction of all tested chemicals was correct in comparison to the classification of the OECD guideline 439.
The prediction and classification of skin corrositivity potential of substances can be performed by the assessment of the effect on EpiDerm models.
The Human Skin Model Test is validated by the EURL ECVAM (European Union Reference Laboratory for Alternatives to Animal Testing) and is performed in accordance with the OECD guidance (OECD 431) at Eurofins BioPharma Product Testing Munich GmbH1 with chemicals, cosmetics or personal care products and pharmaceuticals.
Corrosion represents irreversible tissue damage of the skin (visible necrosis) after application of chemicals. The underlying mechanisms are either the destruction of the skin penetration barrier or the rapid penetration of highly cytotoxic chemicals through the skin without its destruction. |
Principles of the Human Skin Model Test
Protocol |
||
Model |
EpiDerm |
|
Supplier |
MatTek |
|
Analysis |
Corrosivity potential: cytotoxicity measurement with MTT (mean tissue viability compared to negative control) |
|
Test chemical concentrations |
Liquids: 50 µL (undiluted) Solids: 25 mg + 25 µL H2O |
|
Exposure time |
3 min and 60 min incubation with dose groups |
|
Quality controls |
Positive control: 8 N (KOH) Negative control: H2O |
|
Pre-tests |
To determine if additional controls are needed: NSMTT*: mixing of test item with MTT medium to determine if test item alone can reduce MTT à blue colouring: in main experiment two killed tissues treated with test item and two untreated killed tissues were added as controls NSCliving#: mixing of test item with H2O or isopropanol to determine if strong own colour of test item can discolour at contact with this liquids à optical discolouring (measuring of spectrum): in main experiment two living tissues without incubation with MTT medium were added as controls NSCkilled§: if the two other controls were determined à in main experiment two killed tissues without incubation with MTT medium were added as controls |
|
Application |
Direct topical application of chemicals on skin tissue Two tissue replicates per dose group |
|
Data delivery |
Optical density (OD) value with microplate spectrophotometer at 570 nm |
*NSMTT: non-specific MTT reduction
#NSCliving: non-specific colouring of living tissues
$NSCkilled: non-specific colouring of killed tissues
Prediction Model of the Human Skin Model Test
Prediction EpiDerm™ |
|
Mean tissue viability |
Prediction |
Step 1 |
|
< 50% after 3 min exp. |
Corrosive |
³ 50% after 3 min exp. and < 15% after 60 min exp. |
Corrosive A combination of optional sub-categories 1B and 1C |
³ 50% after 3 min exp. and |
Non-Corrosive |
Step 2 |
|
< 25% after 3 min exp. |
Optional sub-category 1A |
|
|
Exp. = exposure
Table 1: Prediction model of the corrosivity potential of the EpiDermTM tissues dependent on the mean tissue viability.1
Based on the mean tissue viability, chemicals can be classified with the skin corrosion test into corrosive and non-corrosive and can be furthermore sub-categorised.
Eurofins Data for demonstration technical proficiency of the Human Skin Model Test (EpiDermTM)
Chemical |
UN GHS category |
EF category for EpiDerm™ |
Corrosive chemicals (sub-category 1A) |
||
Bromoacetic acid |
1A |
1A |
Boron trifluoride dihydrate |
1A |
1A |
Phenol |
1A |
1A |
Dichloroacetyl chloride |
1A |
1A |
Corrosive chemicals (combination of sub-categories 1B and 1C) |
||
Glyoxylic acid monohydrate |
1B and 1C |
1B and 1C |
Lactic acid |
1B and 1C |
1B and 1C |
Ethanolamine |
1B and 1C |
1B and 1C |
Hydrochloric acid (14.4%) |
1B and 1C |
1B and 1C |
Non-corrosive chemicals |
||
Phenethyl bromide |
NC |
NC |
4-Amino-1,2,4-triazole |
NC |
NC |
4-(Methylthio)-benzaldehyde |
NC |
NC |
Lauric acid |
NC |
NC |
EF = Eurofins Munich GmbH NC = Non-Corrosive
Table 2: Eurofins data of in vitro skin corrosion with EpiDerm™ of twelve tested proficiency chemicals compared to the data of the OECD guideline 431 1.
In Table 2 the obtained data from the in vitro skin corrosion with EpiDerm™ of eight corrosive and four non-corrosive chemicals are shown. The prediction of all tested chemicals was correct in comparison to the classification of the OECD guideline 431.
The prediction and classification of skin corrositivity potential of substances can be performed by the assessment of the effect on the Corrositex® Test Method.
The In vitro Membrane Barrier Test Method is validated by the ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods) and is performed in accordance with the OECD guidance (OECD 435) at Eurofins BioPharma Product Testing Munich GmbH1 with chemicals, cosmetics or personal care products and pharmaceuticals.
Principles of the Corrositex®Test Method
Protocol |
|
Model |
Corrositex®Test Method |
Supplier |
InVitro International |
Analysis |
Corrosivity potential: Time of a sample to break through a synthetic macromolecular bio-barrier to active the underlying CDS* is measured and category is read using a Prediction Table. |
Test chemical concentrations |
Liquids: 500 µL (undiluted) Solids: 500 mg (undiluted) |
Exposure time |
Depends on the Categorisation Test: up to 240 min (Category 1) up to 60 min (Category 2) |
Quality controls |
Positive control: Phosphoric Acid (85%) Negative control: Citric Acid (10%) in Aqua dest. |
Steps of the Test |
Qualification Test: This step ensures that the sample is compatible with the Corrositex® system. 100 mg or 150 µL of the sample are added to Qualify test tube (CDS*). If the colour or consistency of the CDS* changes at the sample/testing fluid interface, the test item is qualified for the assay. If no reaction is observed within five minutes, the sample is not qualified for the Corrositex® Assay.
Preparation of Biobarrier: The synthetic macromolecular bio-barrier is prepared, pipetted into membrane discs and kept cool until start of the test.
Categorisation Test: This step establishs the category of cut-off times (up to 240 min or up to 60 min) for the sample. 100 mg or 150 µL of the sample are added to different tubes and checked for a colour change that is matched to the corresponding colour charts of the Corrositex® Testing Protocol Poster.
Classification Test: This step determins the appropriate Packing Group for the test sample. 500 mg or 500 µL of the sample are added to the synthetic macromolecular bio-barrier that is placed onto the CDS* vial. As soon as a reaction is observed in the CDS*, the time is recorded. |
Application |
Direct topical application of chemicals on a synthetic macromolecular bio-barrier with underlying CDS* Four replicates per dose group |
Data delivery |
The mean time of four replicates to active the CDS* is calculated. The appropriate Packing Group Designation, Hazard Statement and UN GHS Subcategory Prediction by sample category is read from the Corrositex® Table (see below). |
*CDS: Chemical Detection System
Prediction Model of the Corrositex® Test Method
Category |
Time [min] |
Time [min] |
Time [min] |
Time [min] |
1 |
0 – 3 |
> 3 - 60 |
> 60 - 240 |
> 240 |
2 |
0 - 3 |
> 3 - 30 |
> 30 - 60 |
> 60 |
UN GHS Subcategory |
1A |
1B |
1C |
non corrosive |
Packing Group |
1 |
2 |
3 |
not applicable |
Hazard Statement |
H314 |
H314 |
H314 |
no label |
Table 1: Prediction model of the corrosivity potential using the Corrositex® Test Method dependent on the mean breakthrough time.1
Based on the mean breakthrough time, samples can be classified with the skin corrosion test into corrosive and non-corrosive and can be furthermore sub-categorised.
Eurofins Data for demonstration technical proficiency of the In Vitro Membrane Barrier Test Method (Corrositex®)
Chemical |
UN GHS category |
EF category for Corrositex® |
Corrosive chemicals (sub-category 1A) |
||
Boron trifluoride dihydrate |
1A |
1A |
Nitric acid |
1A |
1A |
Phosphorus pentachloride |
1A |
1A |
Corrosive chemicals (sub-category 1B) |
||
Valeryl chloride |
1B |
1B |
Sodium Hydroxide |
1B |
1B |
1-(2-Aminoethyl) piperazine |
1B |
1B |
Corrosive chemicals (sub-category 1C) |
||
Benzenesulfonyl chloride |
1C |
1C |
N,N-Dimethyl benzylamine |
1C |
1C |
Tetraethylenepentamine |
1C |
1C |
Non-corrosive chemicals |
||
Eugenol |
NC |
NC |
Sodium bicarbonate |
NC |
NC |
EF = Eurofins Munich GmbH NC = Non-Corrosive
Table 2: Eurofins data of in vitro skin corrosion with Corrositex® of eleven tested proficiency chemicals compared to the data of the OECD guideline 435 1.
In Table 2 the obtained data from the In Vitro Membrane Barrier Test Method (Corrositex®) of nine corrosive and two non-corrosive chemicals are shown. The prediction of all tested chemicals was correct in comparison to the classification of the OECD guideline 435 1.
At Eurofins Biopharma Product Testing Munich GmbH the Human Skin Model Test can be used for detection of skin irritation potential of medical devices. The prediction and classification can be done by the assessment of the effect on EpiDermTM model or SkinEthicTM RHE model.
The modified Human Skin Model Test for medical devices is a reliable in vitro test method and is performed in accordance with the draft ISO guidelines 10993-12 and 10993-23 Part 10 at Eurofins1.
Acute irritation characterises a local, reversible inflammatory response of normal living skin to direct injury after application of irritant substances2. |
Principles of the Human Skin Model Test with Medical Devices
Protocol |
||
Model |
EpiDermTM (Reconstructed human skin model) supplied from MatTek |
SkinEthicTM RHE (Reconstructed human skin model) supplied from EpiSkin |
Analysis |
skin irritation potential: cytotoxicity measurement with MTT (mean tissue viability compared to negative control tissues) optional: Interleukin-1α (IL-1α) release into the tissue culture medium |
|
Test chemical concentrations |
100 µL undiluted extract in 0.9% NaCl (polar) 100 µL undiluted extract in sesame oil (non-polar) |
|
Extraction and absorption capacity |
extraction at 37 ± 1 °C for 72 ± 2 h in 0.9% NaCl or sesame oil with continuous agitation/shaking determination of the absorption capacity of the test item in NaCl (polar) or in sesame oil (non-polar) |
|
Exposure time |
18 ± 0.5 h in the incubator |
24 ± 2 h in the incubator |
Quality controls |
positive control: 1% SDS in NaCl and sesame oil negative control: DPBS vehicle controls: → 0.9% NaCl as solvent for polar extracts → sesame oil as solvent for non-polar extracts |
|
Pre-tests |
to determine if additional controls are needed: NSMTT*: mixing of test item extract with MTT medium to determine if test item alone can reduce MTT → blue colouring: in main experiment two killed tissues treated with test item and two (EpiDerm™) or three (SkinEthic™ RHE) untreated killed tissues were added as controls NSCliving*: mixing of test item extract with H2O or isopropanol to determine if strong own colour of test item can discolour at contact with this liquids → optical discolouring (measuring of spectrum): in main experiment two (EpiDerm™) or three (SkinEthic™ RHE) living tissues without incubation with MTT medium were added as controls NSCkilled*: if the two other controls were determined → in main experiment two (EpiDerm™) or three (SkinEthic™ RHE) killed tissues without incubation with MTT medium were added as controls |
|
Application |
direct topical application of extracts on skin tissues three tissue replicates per dose group |
|
Data delivery |
optical density (OD) value with microplate spectrophotometer at 570 nm tissue viability of each dose group |
|
Prediction model |
mean tissue viability (% negative control): ≤ 50%: Irritant; (IL-1α > 60 pg/mL) > 50%: Non-Irritant; (IL-1α ≤ 60 pg/mL) |
*NSMTT: non-specific MTT reduction
#NSCliving: non-specific colouring of living tissues
§NSCkilled: non-specific colouring of killed tissues